Duration of Follow Up for New Molecular Entities Approved in 2017

    Basic Details
    Date Posted
    Friday, August 13, 2021
    Status
    Complete
    Medical Product
    new molecular entities (NMEs)
    Description

    The purpose of this analysis was to investigate the duration of follow-up time available for users of New Molecular Entities (NMEs) approved in 2017, stratified by age, sex, and calendar year, in the Sentinel Distributed Database (SDD). This analysis includes two reports:

    • Report 1: We investigated the duration of follow-up time available for users of 23 NMEs approved between January and June of 2017. We distributed this request to 16 Sentinel Data Partners on March 19, 2020.
    • Report 2: We investigated the duration of follow-up time available for users of 25 NMEs approved between July and December of 2017. We distributed this request to 16 Sentinel Data Partners on March 20, 2020.